ClariVest Asset Management LLC - PDL BIOPHARMA INC ownership

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 232 filers reported holding PDL BIOPHARMA INC in Q3 2014. The put-call ratio across all filers is 1.63 and the average weighting 0.0%.

Quarter-by-quarter ownership
ClariVest Asset Management LLC ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q3 2020$7,000
+16.7%
2,1240.0%0.00%
Q2 2020$6,0000.0%2,1240.0%0.00%
Q1 2020$6,000
-14.3%
2,1240.0%0.00%
Q4 2019$7,000
+40.0%
2,1240.0%0.00%
Q3 2019$5,000
-28.6%
2,1240.0%0.00%
Q2 2019$7,000
-12.5%
2,1240.0%0.00%
Q1 2019$8,000
-94.9%
2,124
-96.1%
0.00%
-100.0%
Q4 2018$157,000
-8.7%
54,231
-17.2%
0.00%0.0%
Q3 2018$172,000
+12.4%
65,5180.0%0.00%0.0%
Q2 2018$153,000
-20.3%
65,5180.0%0.00%0.0%
Q1 2018$192,000
+22.3%
65,518
+14.6%
0.00%0.0%
Q4 2017$157,000
-18.7%
57,1710.0%0.00%
-25.0%
Q3 2017$193,000
+41.9%
57,171
+4.0%
0.00%
+33.3%
Q2 2017$136,000
+9.7%
54,9760.0%0.00%0.0%
Q1 2017$124,000
-67.8%
54,976
-69.8%
0.00%
-70.0%
Q4 2016$385,000
-37.6%
182,292
-0.9%
0.01%
-44.4%
Q3 2016$617,000
+50.9%
183,955
+41.2%
0.02%
+50.0%
Q2 2016$409,000
+8.8%
130,252
+15.5%
0.01%
+9.1%
Q1 2016$376,000
-1.8%
112,752
+4.2%
0.01%0.0%
Q4 2015$383,000
-31.4%
108,246
-2.3%
0.01%
-35.3%
Q3 2015$558,000
-23.4%
110,788
-2.2%
0.02%
-22.7%
Q2 2015$728,000
-8.8%
113,288
-0.2%
0.02%
-8.3%
Q1 2015$798,000
-9.9%
113,464
-1.3%
0.02%
-22.6%
Q4 2014$886,000
+2.4%
114,966
-0.7%
0.03%
-3.1%
Q3 2014$865,000
-22.9%
115,796
-0.1%
0.03%
-23.8%
Q2 2014$1,122,000
+115.8%
115,900
+85.1%
0.04%
+100.0%
Q1 2014$520,00062,6110.02%
Other shareholders
PDL BIOPHARMA INC shareholders Q3 2014
NameSharesValueWeighting ↓
Argent Trust Co 41,405$102,2700.01%
Diversified Trust Co 11,029$26,4690.00%
HANCOCK WHITNEY CORP 128,396$00.00%
RHUMBLINE ADVISERS 612$1,5110.00%
Ancora Advisors LLC 4,948$00.00%
Westside Investment Management, Inc. 500$00.00%
View complete list of PDL BIOPHARMA INC shareholders